Xianling Liu

831 total citations
33 papers, 506 citations indexed

About

Xianling Liu is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Xianling Liu has authored 33 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Xianling Liu's work include Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (5 papers) and Head and Neck Cancer Studies (5 papers). Xianling Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (5 papers) and Head and Neck Cancer Studies (5 papers). Xianling Liu collaborates with scholars based in China, United States and France. Xianling Liu's co-authors include Yuhua Feng, Yawen Gao, Lizhen Yang, Hong Zhang, Min Xu, Xinge Zhao, Xin Li, Jianjun Tang, Bilian Yu and Liang Tang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Xianling Liu

32 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xianling Liu China	10	175	148	130	94	82	33	506
Rodrigo Benedetti Gassen Brazil	12	210 1.2×	138 0.9×	68 0.5×	99 1.1×	45 0.5×	29	693
Jian‐Da Ma China	15	99 0.6×	173 1.2×	57 0.4×	170 1.8×	56 0.7×	38	671
G. Ehninger Germany	15	170 1.0×	162 1.1×	49 0.4×	106 1.1×	47 0.6×	56	859
James Tiesinga United States	11	175 1.0×	184 1.2×	50 0.4×	100 1.1×	66 0.8×	19	688
Jonathan M. Keller United States	11	117 0.7×	262 1.8×	44 0.3×	54 0.6×	58 0.7×	22	610
Michail Galanopoulos Greece	12	194 1.1×	152 1.0×	87 0.7×	116 1.2×	99 1.2×	37	543
Jieyu Ye China	14	154 0.9×	190 1.3×	96 0.7×	70 0.7×	29 0.4×	49	695
Liang Luo China	14	131 0.7×	361 2.4×	47 0.4×	128 1.4×	177 2.2×	34	656
Helen Enright Ireland	14	68 0.4×	81 0.5×	76 0.6×	91 1.0×	14 0.2×	41	625
Min Sung Chung South Korea	14	204 1.2×	174 1.2×	30 0.2×	67 0.7×	128 1.6×	56	637

Countries citing papers authored by Xianling Liu

Since Specialization

Citations

This map shows the geographic impact of Xianling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianling Liu more than expected).

Fields of papers citing papers by Xianling Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianling Liu. The network helps show where Xianling Liu may publish in the future.

Co-authorship network of co-authors of Xianling Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianling Liu. A scholar is included among the top collaborators of Xianling Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianling Liu. Xianling Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Sujuan, et al.. (2024). Predicting the overall survival and progression‐free survival of nasopharyngeal carcinoma patients based on hemoglobin, albumin, and globulin ratio and classical clinicopathological parameters. Head & Neck. 46(10). 2600–2615. 1 indexed citations

Li, Yajun, Kailin Chen, Bihua Chen, et al.. (2024). Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma. Leukemia. 38(7). 1553–1563. 5 indexed citations

Deng, Yuping, et al.. (2023). Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis. BMC Cancer. 23(1). 905–905. 4 indexed citations

Hong, Huangming, Le Yu, Zhihui Zhang, et al.. (2023). Primary breast diffuse large B‐cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group. Cancer Medicine. 12(23). 21188–21198. 2 indexed citations

Deng, Chao, Xianling Liu, Shun Jiang, et al.. (2023). Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil. Frontiers in Immunology. 14. 7 indexed citations

Liu, Chaoyuan, Liang Zeng, Chao Deng, et al.. (2023). Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer. Frontiers in Immunology. 14. 1175960–1175960. 6 indexed citations

Deng, Chao, Sujuan Zhang, Yuhua Feng, et al.. (2023). Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy. Scientific Reports. 13(1). 20630–20630. 3 indexed citations

Xu, Chao, Lei Zhang, Ran Xu, et al.. (2023). Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer. Frontiers in Immunology. 14. 1162580–1162580. 5 indexed citations

Li, Xuping, Zhaowei Zhu, Jun Liu, et al.. (2023). Septal radioablation therapy for patients with hypertrophic obstructive cardiomyopathy: first-in-human study. European Heart Journal Open. 3(3). oead052–oead052. 4 indexed citations

10.

Wang, Zhihua, Jieping Li, Yongheng Chen, et al.. (2022). A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling. Frontiers in Oncology. 12. 870676–870676. 3 indexed citations

11.

Liu, Chaoyuan, Min Lü, Yang Yang, et al.. (2022). Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation. Frontiers in Oncology. 12. 961539–961539. 4 indexed citations

12.

Wang, Sisi, Yuhua Feng, Yangchun Xie, et al.. (2022). High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection. European Archives of Oto-Rhino-Laryngology. 279(9). 4541–4548. 6 indexed citations

13.

Li, Jin, Yajun Li, Meizuo Zhong, et al.. (2020). <p>Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis</p>. Therapeutics and Clinical Risk Management. Volume 16. 1151–1163. 1 indexed citations

14.

Feng, Yuhua, Meizuo Zhong, Youhong Tang, et al.. (2020). The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma. Molecular Therapy — Nucleic Acids. 21. 452–463. 23 indexed citations

15.

Feng, Yuhua, Sisi Wang, Yan He, et al.. (2020). Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study. Frontiers in Oncology. 10. 575417–575417. 35 indexed citations

16.

Gao, Yawen, Lihua Luo, Yangchun Xie, et al.. (2020). PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Molecular Carcinogenesis. 59(5). 503–511. 44 indexed citations

17.

Li, Yajun, Pingyong Yi, J Y Li, et al.. (2017). Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study. Chinese Journal of Cancer. 36(1). 62–62. 8 indexed citations

18.

Tan, Shengyu, Xianling Liu, Yan Xu, et al.. (2016). Serum high-density lipoprotein correlates with serum apolipoprotein M and A5 in obstructive sleep apnea hypopnea syndrome. Sleep And Breathing. 21(1). 37–44. 5 indexed citations

19.

Wang, Jingjing, et al.. (2015). Role of radiotherapy in the treatment of primary mediastinal large B-cell lymphoma. Oncology Letters. 10(5). 2925–2930. 5 indexed citations

20.

Wang, Anping, Meilian Liu, Xianling Liu, et al.. (2010). Up-regulation of Adiponectin by Resveratrol. Journal of Biological Chemistry. 286(1). 60–66. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact